Check out what our partners are saying about us:

---

“As we were looking to source out our IND-enabling studies, BioPulse Consulting came highly recommended. To put this to the test, BioPulse placed a small PK study in NHPs that met our budget and timelines. The success of this small study led to further projects, and ultimately, BioPulse became our go-to for the remaining studies in the program. 

As a startup with multiple assets in the pipeline, we needed CRO selection and management support. BioPulse came through in supporting our IND-enabling studies with CRO/CDMO selection, management, and communication, acting as the outsourcing arm for us at no cost. BioPulse’s understanding of our compound and vision, their consultative approach, and their vast CRO/CDMO network ensured a very successful relationship between the two companies. We highly recommend BioPulse Consulting for all of your CRO/CDMO needs from discovery all the way to the clinic. BioPulse truly lives up to being “With you. Along the way!””

                                                                                                                                       Co-Founder & CEO-Biopharma Startup 

“I worked with BioPulse on two different PK/PD  projects.  The objective was to investigate the PK/PD of a drug in nonhuman primates (NHP) after single and repeat dosing.  I screened couple of the known CROs and their prices were beyond my budget.  I didn’t have the time to contact other CROs due to competing work priorities.   A friend of mine told me about BioPulse and I’m glad that I contacted them. They were very professional and very responsive. They understood my budget restrictions and they screened multiple CROs on my behalf.  They negotiated prices and collected quotes that were under the allocated budget. This allowed me to add more dosing groups to better assess the exposure-response relationship.  Due to the success of the first project we utilized the network of BioPulse to run a second NHP study. Both projects were successfully completed.  Prices were very favorable, as BioPulse is compensated by the CRO and not the pharma company. The study designs were very complicated and I’m very satisfied with the quality of the work and the skill sets at the selected CRO.  I would highly recommend BioPulse for any preclinical work.”
                                                                                                                                   Principal Scientist-Biopharma Company

"BioPulse consulting was recommended to me by several members of my professional network when my company was looking for experts in preclinical genotoxicity evaluation of New Chemical Entities.   In addition to their key services in identifying and connecting clients with the appropriate CROs, BioPulse has a wide network of consultants.  For our particular need, they connected us with two experts, one with vast experience on the scientific/technical side, and the other on the regulatory side.  Both did an excellent job in mapping out and presenting various options, as well as collaborating with our already existing pre-clinical CRO to get optimum results.  We highly recommend BioPluse to any biopharmaceutical company that is looking for speed, quality, flexibility within a tight budget and aggressive timelines."

                                                                                                                                   Vice President-Biopharma Company